Nreu, Besmir

Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials

Monami, M., Nreu, B., Scatena, A., Cresci, B., Andreozzi, F., Sesti, G., & Mannucci, E. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 243

Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials

Dicembrini, I., Nreu, B., Mannucci, E., & Monami, M. (2019) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 85

Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

NREU, B., DICEMBRINI, I., TINTI, F., MANNUCCI, E., & MONAMI, M. (2023) · Minerva Endocrinology

Diabetes Treatment and ManagementPancreatic and Hepatic Oncology Research

Cited by 63

Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials

Nreu, B., Dicembrini, I., Tinti, F., Mannucci, E., & Monami, M. (2020) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementGallbladder and Bile Duct Disorders

Cited by 32

Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

Nreu, B., Dicembrini, I., Tinti, F., Mannucci, E., & Monami, M. (2020) · Minerva Endocrinology

Diabetes Treatment and ManagementPancreatic and Hepatic Oncology Research

Cited by 27

Immune checkpoints inhibitors and hyperglycemia: A meta-analysis of randomized controlled trials

Monami, M., Naletto, L., Nreu, B., Dicembrini, I., Sesti, G., & Mannucci, E. (2020) · Diabetes Research and Clinical Practice

Cancer Immunotherapy and BiomarkersDiabetes and associated disorders

Cited by 12